Hg, the manager of U.K.-headquartered investment company HgCapital Trust plc (HGT.L) on Friday announced a full exit of Intelerad, engaged in medical imaging software solution, to GE Healthcare.
As a result of the transaction that values Intelerad at $2.3 billion, Hg would fully exit its majority shareholding in Intelerad. TA Associates and Ardan Equity would also exit minority positions in the business.
Further terms of the deal have not been disclosed.
Hg partnered on the original Intelerad investment with Ardan Equity. This transaction values HgT's investment in Intelerad at approximately 52 million pounds implying an uplift of 20 million pounds over the carrying value of 32 million pounds in the pro-forma Net Asset Value of HgT at 30 September 2025. Accordingly, the new pro-forma NAV of HgT is expected to be 2.5 billion pounds or 553.9 pence per share.
HgT's outstanding commitments to invest in Hg transactions are approximately 1.7 billion pounds.
For GE HealthCare, Evercore is serving as financial advisor and Sidley Austin LLP as deal counsel.
For Intelerad, UBS Investment Bank is serving as exclusive financial advisor and Skadden, Arps, Slate, Meagher & Flom LLP as deal counsel.
For comments and feedback contact: editorial@rttnews.com
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.